Active, not recruiting Overweight Chronic Low Back Pain (CLBP) Drug: Retatrutide Drug: Placebo A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis The purpose of this study is to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and activity of RO7790121 in particip
For comparison, see what happens when semaglutide is left out overnight
is approved for weight loss in adults and children ages 12 and over with obesity, and for adults with overweight plus at least one weight-related condition (such as type 2 diabetes or heart disease)
It remains an investigational drug , which means it is available only for clinical trials and research purposes
Semaglutide has been in clinical use since 2017
Through efficient inventory management and strategic sourcing, we help clients maintain uninterrupted access to bulk Retatrutide supplies